Selskabets formål er produktion, køb, salg og marketing af diagnostikudstyr og hermed beslægtede produkter samt anden i forbindelse med disse formål stående virksomhed. Selskabets formål er herudover at eje kapitalandele i andre selskaber.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 76.3 mio. | 2.7 mio. | 25.7 mio. | 8.2 mio. | 8 | |
CVR: 10062462
Compared to 288 companies in Engroshandel med læge- og hospitalsartikler
Comparison is based on industry median values
The financial health of BIOMÉRIEUX DENMARK ApS appears stable, with a slight upward trend in revenue from DKK 70.3 million in 2023 to DKK 76.3 million in 2024, alongside an increase in profit from DKK 2.2 million to DKK 2.7 million. However, equity has decreased from DKK 8.4 million in 2023 to DKK 8.2 million in 2024, indicating potential concerns regarding long-term financial stability. Profit margins have declined over the past few years, with a notable drop from DKK 4.97 million in 2021 to DKK 2.7 million in 2024. Positioned within the medical and hospital supplies wholesale industry, the company remains a key player, but its declining equity and profit margins warrant close monitoring.
AI-generated summary
Companies in the same industry and area
CVR 66351912
CVR 39640163
CVR 35435778
CVR 36184779
CVR 28714084
companydata.dk